Litigation Details for Biogen International GmbH v. Cipla Limited (D. Del. 2019)
✉ Email this page to a colleague
Biogen International GmbH v. Cipla Limited (D. Del. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-11-26 |
| Court | District Court, D. Delaware | Date Terminated | 2020-06-29 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | None | Referred To | |
| Patents | 6,509,376; 7,320,999; 7,619,001; 8,399,514 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Biogen International GmbH v. Cipla Limited
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Biogen International GmbH v. Cipla Limited (D. Del. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-11-26 | 1 | Complaint | this Court against Cipla for patent infringement of U.S. Patent Nos. 6,509,376 {01512114;v1 } …for patent infringement of U.S. Patent No. 7,619,001 (“the ’001 patent”) arising under the patent laws… (“the ’376 patent”), 7,320,999 (“the ’999 patent”) and 8,399,514 (“the ’514 patent”) in Biogen International…C.F.R. § 314.95(c) as to the ’376 patent, ’999 patent, and ’514 patent. The First Suit included counts …counts for infringement of the ’376 patent, ’999 patent and ’514 patent. 12. This complaint | External link to document |
| 2019-11-26 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,619,001. (myr) (Entered: 12…2019 29 June 2020 1:19-cv-02210 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
